Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05827614
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2023-03-27
Brief Title:
Study of the CHK1 Inhibitor BBI-355 an EcDNA-directed Therapy ecDTx in Subjects with Tumors with Oncogene Amplifications
Sponsor:
Boundless Bio
Organization:
Boundless Bio
Organization Data
Organization:
Boundless Bio
Class:
INDUSTRY
Study ID:
BBI-355-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Boundless Bio
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None